Evidence map›Paper›PMID 39187870›Full record

ArticleAIDS research and therapy2024

Kidney transplant recipient with history of HIV, HBV, and past HCV infection.

José Ignacio Cerrillos-Gutiérrez, Ricardo Parra-Guerra, Alfredo Gutiérrez-Govea, Jorge Andrade-Sierra, Eduardo González-Espinoza, Daniel Nuño-Díaz, Martha Jessica Herrera-Rodríguez, Maribel Ávila-Morán, Ana Luisa Corona-Nakamura, Luz Yasmin Hinogiante-Segura and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS research and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

José Ignacio Cerrillos-GutiérrezNephrology and Transplantation Division, UMAE, National Medical Center of the West, Mexican Institute of Social Security, Guadalajara, Mexico.
Ricardo Parra-GuerraNephrology and Transplantation Division, UMAE, National Medical Center of the West, Mexican Institute of Social Security, Guadalajara, Mexico.
Alfredo Gutiérrez-GoveaNephrology and Transplantation Division, UMAE, National Medical Center of the West, Mexican Institute of Social Security, Guadalajara, Mexico. alfredo510923@gmail.com.
Jorge Andrade-SierraNephrology and Transplantation Division, UMAE, National Medical Center of the West, Mexican Institute of Social Security, Guadalajara, Mexico.
Eduardo González-EspinozaNephrology and Transplantation Division, UMAE, National Medical Center of the West, Mexican Institute of Social Security, Guadalajara, Mexico.
Daniel Nuño-DíazNephrology and Transplantation Division, UMAE, National Medical Center of the West, Mexican Institute of Social Security, Guadalajara, Mexico.
Martha Jessica Herrera-RodríguezNephrology and Transplantation Division, UMAE, National Medical Center of the West, Mexican Institute of Social Security, Guadalajara, Mexico.
Maribel Ávila-MoránNephrology and Transplantation Division, UMAE, National Medical Center of the West, Mexican Institute of Social Security, Guadalajara, Mexico.
Ana Luisa Corona-NakamuraNephrology and Transplantation Division, UMAE, National Medical Center of the West, Mexican Institute of Social Security, Guadalajara, Mexico.
Luz Yasmin Hinogiante-SeguraNephrology and Transplantation Division, UMAE, National Medical Center of the West, Mexican Institute of Social Security, Guadalajara, Mexico.
Claudia Alejandra Mendoza-CerpaNephrology and Transplantation Division, UMAE, National Medical Center of the West, Mexican Institute of Social Security, Guadalajara, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic viral infections caused by the human immunodeficiency virus (HIV), hepatitis C (HCV), and hepatitis B (HBV) are common among patients with end-stage renal disease (ESKD). These infections were once considered contraindications to kidney transplantation due to potential risks associated with long-term immunosuppression. Improved management and antiviral therapies have changed the prognosis and survival of this group of patients, along with an increased experience in transplanting people with these viral infections. We report the first successful kidney transplant in an ESKD patient on hemodialysis with a history of concomitant HIV, HCV and HBV infection in Mexico.

Indexed as

HIV InfectionsKidney Failure, ChronicKidney TransplantationAdultHepatitis BHepatitis CHepatitis C, ChronicHumansMaleMexicoMiddle AgedRenal DialysisTreatment Outcome

Identifiers

PMID39187870
PMCPMC11348749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.